BAMCO Inc
AXDX

BAMCO Inc’s Accelerate Diagnostics AXDX Stock Holding History

BAMCO Inc’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,490
Closed -$1.76M – 378
2020
Q3 		$1.76M Hold
16,490
– – 0.01% 295
2020
Q2 		$2.5M Hold
16,490
– – 0.01% 273
2020
Q1 		$1.37M Sell
16,490
-9,510
-37% -$1.34M 0.01% 272
2019
Q4 		$4.39M Hold
26,000
– – 0.02% 261
2019
Q3 		$4.83M Hold
26,000
– – 0.02% 251
2019
Q2 		$5.95M Hold
26,000
– – 0.02% 258
2019
Q1 		$5.46M Hold
26,000
– – 0.02% 248
2018
Q4 		$2.99M Buy
+26,000
New +$3.85M 0.02% 268

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

BAMCO Inc's AXDX Position: Q4 2020 in Review

BAMCO Inc sold out of Accelerate Diagnostics (AXDX) in Q4 2020, closing a stake of 16,490 shares — an estimated $1.76M sold.

BAMCO Inc first reported a position in AXDX in Q4 2018 and held it in 8 quarters. The position peaked at $5.95M in Q2 2019. 115 funds tracked by Wall St. Rank hold AXDX as of Q4 2020.

  • BAMCO Inc reported no remaining Accelerate Diagnostics position as of Q4 2020 after selling out during the quarter.
  • BAMCO Inc sold 16,490 Accelerate Diagnostics shares in Q4 2020, an estimated $1.76M.
  • BAMCO Inc first reported a position in Accelerate Diagnostics in Q4 2018 and held it in 8 quarters.
  • BAMCO Inc's Accelerate Diagnostics position peaked at $5.95M in Q2 2019.
  • 115 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2020.

Based on BAMCO Inc's 13F filing for Q4 2020, filed 12 Feb 2021.